Megan Gorman
Papers
1
Total Citations
2
H-Index
1
About
Megan Gorman is a clinician-researcher whose work focuses on optimizing perioperative care and infection prevention in gynecologic oncology. Her most-cited study, "Addition of metronidazole to standard-of-care perioperative prophylaxis at the time of hysterectomy for gynecologic malignancies" (2025, 2 citations), addresses a critical gap in surgical safety for patients undergoing hysterectomy for cancer. By investigating the role of metronidazole in reducing postoperative infections, Gorman contributes to evidence-based refinements of antibiotic prophylaxis protocols, directly impacting patient outcomes and recovery. Though early in her citation trajectory, this work signals a commitment to improving surgical standards in a high-risk population. Her research bridges clinical pharmacology and oncology surgery, offering practical insights for reducing morbidity. Gorman’s focus on gynecologic malignancies places her at the intersection of infection control and cancer care, where even small protocol adjustments can yield significant benefits. As her work gains recognition, she is poised to influence perioperative guidelines and advance patient safety in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1